To determine whether artemether, a derivative of the antimalarial agent qinghaosu, is therapeutically active against Schistosoma mansoni, we determined the in vitro, in vivo, and histopathologic effects of the drug on S. mansoni worms. In vitro, toxic effects of artemether on S. mansoni were not seen at concentrations of less than 100 ,ug/ml. However, in vivo, 30 Qinghaosu (artemisinin) is a new antimalarial drug derived from a traditional Chinese herbal remedy, qinghao or Artemisia annua L. (7). To enhance the antimalarial activity and solubility of qinghaosu (Fig. 1A) , a series of chemical derivatives of qinghaosu, e.g., artemether and artesunate, have been synthesized and studied in laboratory and clinical trials (8, 13). As a result of these studies, qinghaosu, artemether (Fig. 1B) , and artesunate were found to be active against malarial parasites as well as effective in the treatment of Schistosoma japonicum infections (9, 10). Thus, qinghaosu (2) and its derivatives appear to have antischistosomal as well as antimalarial chemotherapeutic potential. Recently, it was suggested (3) that resistance might be developing to praziquantel, the current drug of choice for the treatment of all species of human schistosomiasis (5). Thus, continued identification and evaluation of new antischistosomal agents are important in the event that clinical resistance to praziquantel therapy develops. Using Schistosoma mansoni-infected mice as a model of infection as well as for a source of parasites for in vitro studies, we investigated the potential usefulness of artemether in the treatment of S. mansoni infections.
Qinghaosu (artemisinin) is a new antimalarial drug derived from a traditional Chinese herbal remedy, qinghao or Artemisia annua L. (7) . To enhance the antimalarial activity and solubility of qinghaosu (Fig. 1A) , a series of chemical derivatives of qinghaosu, e.g., artemether and artesunate, have been synthesized and studied in laboratory and clinical trials (8, 13) . As a result of these studies, qinghaosu, artemether (Fig. 1B) , and artesunate were found to be active against malarial parasites as well as effective in the treatment of Schistosoma japonicum infections (9, 10) . Thus, qinghaosu (2) and its derivatives appear to have antischistosomal as well as antimalarial chemotherapeutic potential. Recently, it was suggested (3) that resistance might be developing to praziquantel, the current drug of choice for the treatment of all species of human schistosomiasis (5) . Thus, continued identification and evaluation of new antischistosomal agents are important in the event that clinical resistance to praziquantel therapy develops. Using Schistosoma mansoni-infected mice as a model of infection as well as for a source of parasites for in vitro studies, we investigated the potential usefulness of artemether in the treatment of S. mansoni infections.
(An abstract of this work was published as part of the proceedings of the Southern Regional Meeting of the American Federation for Clinical Research [Clin. Res. 37:20A, 1989 ].) MATERIALS AND METHODS Animals. Male C3H/HenNCr (C3H) and DBA/2NCr inbred mice weighing 18 to 22 g were obtained through a Veterans Administration contract with the National Cancer Institute, Bethesda, Md. In addition, female CF1 outbred mice, obtained from Jackson Laboratory, Bar Harbor, Maine, were used in early studies on the induction of the hepatic shift of S. mansoni by artemether in infected mice. Animals (C3H and DBA/2NCr mice) were maintained with rodent Blox (Wayne Pet Food Division, Continental Grain Co., Chicago, Ill.) and water ad libitum in the animal care facility of the Veterans Administration Medical Center/ Medical College of Georgia, Augusta, Ga.
Drug. Artemether (Fig. 1B) , a methoxy derivative of reduced qinghaosu, was prepared semisynthetically in the Institute of Parasitic Diseases, Shanghai, People's Republic of China. The drug preparation used in these studies appeared chromatographically as a single peak under the following high-pressure liquid chromatography conditions: mobile phase, 50% acetonitrile-water; flow rate, 2 ml/min; detector setting, 214 nm (model 160 detector; Beckman Instruments, Inc., Fullerton, Calif.); column, 10-cm Spheri-5 ODS-MP (5-R,m diameter) plus 1.5-cm precolumn (Brownlee Labs) at ambient temperature. Further resolution of the peak with different solvent combinations and/or columns was not attempted. Under these conditions, with a chart speed of 10 mm/min, the peak eluted at 9.5 min. The drug was dissolved in polyethylene glycol (PEG 400; Fisher Scientific Co., Pittsburgh, Pa.) and administered to the mice by gavage in a volume of 0.4 ml/20 g of body weight. For in vitro studies, 5 mg of artemether was dissolved in 3 ml of PEG 400 and then diluted to Table 1 ).
Hepatic shift. CF1 female mice infected with 250 S. mansoni cercariae (Puerto Rican strain) by tail immersion were treated orally with artemether at a single dose of 300 mg/kg 6 to 7 weeks after infection. Groups of six mice were killed at different times within 2 weeks after treatment. Schistosomes located in the mesenteric veins and liver were obtained by perfusion by the method of Yolles et al. (16) . The percentage of schistosomes distributed in the abovementioned locations was then calculated.
Therapeutic effect. C3H mice were individually infected with either 90 or 150 cercariae by subcutaneous injection. Seven weeks after infection, mice were treated orally with artemether at various doses (see Table 2 ). The animals were sacrificed 5 weeks after treatment, and the mesenteric veins and liver were perfused and then torn apart to recover the worms. Control mice were divided into two groups. One group of mice was sacrificed 7 weeks after infection to determine the average worm number. The second group of infected control mice was given a single dose of PEG 400 alone (0.4 ml/20 g of body weight per day) daily for 1 to 3 days to assess the effect of PEG 400 alone as well as to determine the survival time of untreated, infected mice. The therapeutic effect of the drug was quantitated by measuring the worm reduction rate.
Histopathologic studies. Infected mice were treated daily with a single oral dose of artemether (300 mg/kg) for 2 days and autopsied at different times within 8 weeks after treatment. Schistosomes lodged in the mesenteric veins and liver were obtained by perfusion with ice-cold HBSS and then fixed in 70% alcohol. These worms were stained with carmine for morphological studies and measurement of worm body, testis, and ovary size. A total of 16 groups containing 10 male and 10 female worms were studied at each time (see Table 1 ).
Effect of artemether on different stages of S. mansoni. C3H mice infected with 100 or 150 cercariae by subcutaneous injection were divided randomly into groups of 10 to 12 animals. In two different experiments (see Table 3 ), individual groups of mice were treated on days 1, 3, 7, 14, 21, 28, 42, and 56 after infection. Artemether dissolved in PEG 400 was given orally at a daily dose of 300 mg/kg for 2 days commencing on the days listed above. Mice in each experimental group were autopsied 5 to 6 weeks after treatment to determine the number of residual worms. The susceptibility of worms to artemether at different developmental stages was determined by counting residual worms at autopsy and calculating the worm reduction rate of each group versus untreated controls.
Statistics. The one-tailed Student t test was used to compare groups.
RESULTS
In vitro effect of artemether on adult schistosomes. No effect on adult worms was noted when the lowest concentrations of PEG 400 (1.5%) and artemether (25 ,ug/ml) were studied. However, when 10 worm pairs were exposed to a medium containing 3 or 6% PEG 400 alone, the worms contracted immediately and showed decreased motor activity. One to two hours later, all worms were no longer contracted but exhibited unnatural movements. When 12 worm pairs were exposed to a medium containing artemether at a concentration of 50 or 100 ,ug/ml dissolved in PEG 400 (final PEG 400 concentrations, 3 and 6%, respectively), the appearance of the worms in the 50-,ug/ml artemether group was similar to the appearance of the worms in the corresponding PEG 400 control group. In the 100-,ug/ml artemether group the worms appeared more elongated and less active, and a few male and female worms had some tegumental damage. Male and female worms in the 100-,ug/ml artemether group began to die 1 day after incubation. By day 5, 11 of 12 male and 10 of 12 female worms were dead. Similar effects were not seen in the 20 worm pairs maintained in drug-free PEG 400-containing medium over the same period of incubation.
Morphological alterations in schistosomes induced by artemether. Infected mice were treated orally with artemether at a daily dose of 300 mg/kg per day for 2 days. Within 1 day after treatment, both male and female worms appeared to be decreased in length (Table 1) . Three days after treatment, the width of the worms was also reduced. Pairs of worms appeared to shrink in length and become thinner within 3 to 21 days after treatment when compared with control worms (P < 0.05) ( Table 1) . By 28 days after treatment, the width of both male and female worms had returned to normal. How- ever, the length of female worms but not that of male worms remained shorter than that of a corresponding control group of worms (P < 0.05) ( Table 1) . Fifty-six days after treatment, the dimensions of male and female worms were similar to those of control worms (Table 1) . Organ-specific damage was assessed by light microscopy with carmine-stained worms. The testes of male worms and the ovaries of female worms showed degeneration and atrophy which resulted in a significant decrease in their size within 14 days after treatment (Table 1 and Fig. 2A to D) . By 28 days after treatment, the size of the testes and ovaries had returned to normal. In a few female worms an almost complete disappearance of the ovary was noted as early as 3 days after treatment, as only a trace of the gland could be detected. Seven days later, the majority of the female worms had only a trace of an ovary. Other morphological alterations included severe degeneration of the vitelline glands in female worms; extension, distortion, and depigmentation of the intestine in both male and female worms; and evidence of attachment of host cells to the surfaces of a few female worms.
Hepatic shift of S. mansoni induced by artemether. Six to seven weeks after female CF1 mice were infected with S. mansoni, 91.2% of male and female worms were located in the mesenteric veins, while 6.5% of the worms were found in the liver (Fig. 3) . When infected mice were treated orally with a single dose of artemeter (300 mg/kg), a shift of the worms towards the liver was observed during the first 8 h after treatment (Fig. 3) . The number of worms appearing in the liver gradually increased from day 1 after treatment, reaching a maximum (99.3%) by day 3. Worms remained in the liver until approximately day 7 and then gradually began to return to the mesenteric veins. However, 75.9% of the worms were still detected in the liver on day 14 (Fig. 3) .
Therapeutic effect of artemether. Different therapeutic doses for artemether treatment were used (Table 2) . Although the average number of worms in each treated group was significantly lower than that in the corresponding control group (P < 0.01), the rate of worm reduction only ranged from 23.8 to 41.2%. Two groups of 10 mice each were used as survival controls. Infected mice treated orally with PEG 400 alone at a daily dose of 0.4 ml/20 g for 1 to 3 days began to die 9 to 10 weeks after infection whether infected with 90 or 150 cercariae. By 11 to 12 weeks over 50% of the mice infected with 90 cercariae and 90% of the mice infected with 150 cercariae were dead. In mice treated with higher doses of artemether (400 or 500 mg/kg), 13.3% in the 400-mg/kg treatment group and 33.3% in the 500-mg/kg treatment group were dead within 1 week after treatment. No further deaths of treated animals at the higher doses were observed during the remaining 3 to 4 weeks of the study.
Effect of artemether on different developmental stages of S. mansoni. Table 3 shows the efficacy of oral artemether after a 2-day treatment course given to groups of mice at different times after infection. In two separate experiments, artemether treatment resulted in no significant reduction of worm burden in the groups treated 1 and 3 days after infection as compared with untreated control animals (P > 0.05) ( Table 3) . Seven-day-old parasites exhibited a moderate susceptibility to artemether which resulted in a significant decrease in average worm number, i.e., a 70% worm reduction rate as compared with that in the control group (P < 0.01). Fourteen-and twenty-one-day-old parasites were the most susceptible to artemether; worm reduction rates of 8.27 to 98.3% and 85.4 to 89.9%, respectively, were noted. In addition, 11 of 23 mice in the day-14 group and 7 of 23 mice in the day-21 group were free of female worms. The susceptibility of 28-, 35-, 42-, and 56-day-old parasites was markedly lower, as evidenced by a lower reduction of worm 
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burden as compared with that in groups treated 14 or 21 days after infection (Table 3) .
DISCUSSION
It has been reported that artemether is effective against adult S. japonicum (10) . When mice infected with adult S. japonicum were treated orally with artemether at a total dose of 400 to 800 mg/kg over a 1-to 4-day course of therapy, worm reduction rates of 55.3 to 79.9% were reported (10) . In our studies of mice infected with S. mansoni, doses as high as 1,200 mg/kg over a 3-to 6-day course resulted in adult worm reduction rates of only 23.8 to 39.1% (Table 2) . Thus, the therapeutic effect of artemether in S. mansoni-infected mice is not dose dependent and is lower against adult S. mansoni than against adult S. japonicum. This observation is particularly interesting because adult S. mansoni worms in general are more susceptible to antischistosomal drugs than are adult S. japonicum worms (5) . Similar differences between species were also seen when stage-specific effects of artemether were studied. In S. mansoni infections, 14-and 21-day-old worms were more susceptible to artemether, while 7-, 28-, and 35-day-old or older adult worms exhibited less susceptibility to the drug. In S. japonicum infections, 7-day-old parasites but not 14-or 21-day-old parasites were reported to be particularly susceptible to artemether (10), indicating that these two species of schistosomes appear to be affected differently by the drug.
Artemether has a slow therapeutic effect on adult S. mansoni. This effect is characterized by a shift of the worms to the liver within 8 h after drug administration, an apparent reduction in size of both male and female worms, and degeneration of reproductive organs. Although all of these drug-induced alterations may last for 3 to 4 weeks after the cessation of treatment (Table 1) , only a small percentage of adult worms are killed, as determined by efficacy studies. Analysis of the effect of artemether on adult worms in vitro indicates that the drug has a lethal effect only when worms are maintained in a medium containing 100 ,ug of artemether per ml and 6% PEG 400. In vitro, therefore, artemether has little direct effect on adult S. mansoni. Similar studies have not been reported with S. japonicum. Whether adult worms that survive treatment regain functional integrity and resume egg laying is not known.
Artemether, a semisynthetic derivative of the naturally occurring sesquinterpene lactone qinghaosu, is characterized by having an endoperoxide bridge within the molecule (Fig. 1B) . Whether the endoperoxide bridge is essential for antischistosomal activity, as it is for antimalarial activity (8), is not known. In Plasmodium falciparum, qinghaosu and its derivatives appear to inhibit protein synthesis more effectively (6) than nucleic acid synthesis (11) . More recent data suggest that quinghaosu-induced oxidant stress may be more important (8) . Under in vivo conditions, the metabolism of the endoperoxide linkage of qinghaosu and its derivatives by malarial or schistosomal parasites may generate oxygen radicals which are detrimental to parasite macromolecules. 
